MHT and Endometrial Protection

Trending3.5(New)

Although menopausal hormone therapy (MHT) is frequently used to treat menopausal symptoms, endometrial safety requires cautious prescription. The significance of endometrial protection is the main topic of this module. Progestogen plays a key role in avoiding hyperplasia and cancer when estrogen is utilized. When starting and monitoring MHT, it helps medical providers make safe, evidence-based decisions.

7 Modules1 hour
$169$0
MHT and Endometrial Protection

Learning Outcomes

What you'll learn

  • The purpose and components of MHT
  • Explain the need for endometrial protection in therapy
  • Identify risks of unopposed estrogen use
  • Recognise appropriate MHT regimens
  • Monitor patients for safety and effectiveness
  • Provide patient education and counselling
Healthcare trainingHealthcare training

Modules

  • Introduction to MHT
  • Understanding Endometrial Protection
  • MHT Regimens and Options
  • Risks and Safety Considerations
  • Monitoring and Follow-Up
  • Patient Education and Counselling
  • Summary
Healthcare trainingHealthcare trainingHealthcare trainingHealthcare trainingHealthcare trainingHealthcare trainingHealthcare training

Top reviews

No reviews yet.

You May Also Like

Learn Anytime
Anywhere

Experience the next level of learning with the Care Learning app. Available on Android and iOS.

Download on the App StoreGet it on Google Play

Come and Work
with Us!

Join us as a healthcare trainer providing practical sessions to professionals and workers.

Apply for Trainer Role

In-Person Practical
Healthcare Training

Enroll in our accredited, hands-on practical training sessions to deliver better patientcentred care.

Apply for Training

Refer &
Earn Rewards.

Invite healthcare professionals to join Care Learning and earn rewards for every successful referral.

1 / 4

Frequently Asked Questions

Hormone therapy used to manage menopausal symptoms.

To prevent abnormal growth of the uterine lining.

Estrogen given without progestogen.

Women with an intact uterus on estrogen therapy.

Endometrial hyperplasia if not properly managed.

Regularly, based on clinical guidance.